04/092026

Heparins Manufacturer: Jiulong’s Innovative Solutions for Global Anticoagulant Markets

Astheglobalanticoagulantmarketcontinuestoexpand—projectedtoreachUSD65.45billionby2025—thedemandforareliableHeparinsManufacturerhasbecomeincreasinglycriticalforpharmaceuticalcompanies,healthcareprovi

Click to view

04/082026

Dalteparin Sodium: Jiulong’s Precision-Manufactured Anticoagulant for Global Healthcare Needs

Astheglobalburdenofthromboembolicdisorderscontinuestorise—withtheDalteparinSodiummarketprojectedtoreachUSD1990millionin2026andgrowata6.1％CAGRthrough2032—thedemandforhigh-quality,predictablelowmolecu

Click to view

04/072026

Enoxaparin Sodium: Trusted API for Global Anticoagulant Excellence

Inmoderncardiovascularandsurgicalhealthcare,EnoxaparinSodiumremainsthegold-standardlowmolecularweightheparin(LMWH),deliveringpredictable,safeanticoagulationformillionsworldwide.Astheglobalmarketsurges

Click to view

04/032026

Enoxaparin Sodium: Jiulong’s Green-Manufactured Anticoagulant for Global Healthcare

Astheglobalburdenofcardiovasculardiseasesandthromboticdisordersgrows—withtheEnoxaparinSodiummarketprojectedtoreachUSD4912.33millionby2035ataCAGRof8.3%—thedemandforhigh-quality,sustainableanticoagula

Click to view

04/022026

Enoxaparin Sodium Supplier: Jiulong’s GMP-Certified Anticoagulant Solutions for Global Markets

Intheglobalcardiovascularandpharmaceuticalindustry,partneringwithareliableEnoxaparinSodiumSupplieriscriticalforpharmaceuticalmanufacturers,hospitals,andhealthcaredistributorsaimingtodeliversafe,effect

Click to view

News and information